IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 85 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 4,839,895 | $12,342,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 65,448 | $167,000 | 0.02% |
| MYCIO WEALTH PARTNERS, LLC | 55,815 | $142,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 187,445 | $478,000 | 0.01% |
| ZACKS INVESTMENT MANAGEMENT | 168,781 | $430,000 | 0.01% |
| Candriam S.C.A. | 290,000 | $740,000 | 0.01% |
| Assenagon Asset Management S.A. | 355,728 | $907,000 | 0.01% |
| Palo Alto Investors LP | 77,044 | $196,000 | 0.01% |
| HOLLENCREST CAPITAL MANAGEMENT | 21,571 | $55,000 | 0.01% |
| Walleye Capital LLC | 16,022 | $41,000 | 0.01% |